Tech Company Financing Transactions
CoTherix Funding Round
CoTherix, based in South San Francisco, secured $55 million from MPM Capital, Alta Partners and Edbi.
Transaction Overview
Company Name
Announced On
10/14/2003
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series C
Investors
MPM Capital (Lead Investor) (Nick Simon)
Alta Partners (Daniel Janney)
Sofinnova Ventures (James Healy)
Proceeds Purpose
CoTherix intends to use the proceeds of the fundraising to in-license and develop late-stage therapeutics.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
5000 Shoreline Court 101
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Not Recorded
Overview
CoTherix, Inc. is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the potential treatment of cardiovascular diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Santel
Browse more venture capital transactions:
Prev: 10/14/2003: Transmode Systems venture capital transaction
Next: 10/14/2003: Phenomix venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs